Michael B. Harlin
Advertisement
Partner at Neal Gerber Eisenberg, specializing in life sciences intellectual property.
Articles by Michael B. Harlin
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Pannel Votes to Loosen Restrictions for Four Peptides
2
Where the True Bottlenecks Exist at FDA for Clinical Trials
3
argenx Acquires Forte Biosciences for $2.2 Billion
4
Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides
5